Provincial Coverage of Drug Treatments Announced in Alberta: Amylyx Pharmaceuticals Canada’s ALBRIOZA™ and Mitsubishi Tanabe Pharma Canada’s RADICAVA ORS®.

The ALS Society of Alberta is pleased to announce that the provincial government has taken a significant step toward improving the lives of individuals living with amyotrophic lateral sclerosis (ALS) by introducing public coverage for both ALBRIOZA™ and RADICAVA ORS®.

ALBRIOZA™ is Amylyx Pharmaceuticals Canada’s new drug treatment for ALS while RADICAVA ORS® is an orally administered formulation of Mitsubishi Tanabe Pharma Canada’s existing RADICAVA IV® infusion drug treatment.

ALS, also known as Lou Gehrig's disease, is a devastating neurodegenerative disease that affects the nerve cells in the brain and spinal cord. There is no known cure for ALS, yet. Currently, the goal of available treatments is to manage symptoms and slow down the progression of the disease, giving individuals living with ALS more time to spend with their loved ones.

The addition of these treatments to the list of provincially covered medications is a ray of hope for Alberta’s ALS community. Both ALBRIOZA™ and RADICAVA ORS® have shown promising results in clinical trials, offering potential benefits in terms of improved quality of life for those living with ALS.

The Society applauds the provincial government's commitment to prioritizing the health and well-being of Albertans living with ALS. Time is not a luxury afforded to those affected by ALS, and the inclusion of these treatments in provincial coverage ensures ease of access for those who need it most.

The ALS Society of Alberta would like to express gratitude to the provincial government for its ongoing support and collaboration in addressing the time-sensitive challenges faced by individuals living with and families affected by ALS. Together, we can continue to make each day the best possible day for those living with this disease.

For more information on ALS, the Society, available resources, and support, please reach out to the ALS Society of Alberta. We remain committed to advocating for change, facilitating the provision of care, promoting awareness, and helping find a cure for ALS.